Jay Duker
Directeur Général chez EYEPOINT PHARMACEUTICALS, INC.
Fortune : 839 027 $ au 30/04/2024
Profil
Jay S.
Duker founded Hemera Biosciences, Inc. in 2010, where he is working as Director from 2010.
Dr. Duker also currently works at EyePoint Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2023 and Thaena, Inc., as Director.
Dr. Duker also formerly worked at Tufts Medical Center, Inc., as Professor & Chairman-Ophthalmology Department, Sesen Bio, Inc., as Chairman from 2020 to 2023, Tufts University School of Medicine, as Chairman-Ophthalmology & Professor from 2001 to 2021, New England Eye Center, as Director from 2001 to 2021, and New England Eye Center, as Director.
Dr. Duker received his undergraduate degree from Harvard University and doctorate degree from Sidney Kimmel Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 23/04/2024 | 51 920 ( 0,10% ) | 839 027 $ | 30/04/2024 |
Postes actifs de Jay Duker
| Sociétés | Poste | Début |
|---|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Directeur Général | 10/07/2023 |
Hemera Biosciences, Inc.
 Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Fondateur | 01/01/2010 |
Thaena, Inc.
 Thaena, Inc. BiotechnologyHealth Technology Thaena, Inc. engages in biotechnology industry. The company was founded in 2019 and is headquartered in Portland, OR. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jay Duker
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Président | 07/03/2023 |
New England Eye Center
 New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Directeur/Membre du Conseil | 01/10/2021 |
| Tufts University School of Medicine | Corporate Officer/Principal | 01/01/2021 |
Tufts Medical Center, Inc.
 Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Formation de Jay Duker
| Harvard University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Hemera Biosciences, Inc.
Hemera Biosciences, Inc. Pharmaceuticals: GenericHealth Technology Hemera Biosciences, Inc. is a biotechnology company. It develops anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration. The company was founded by Adam Rogers and Jay S. Duker in 2010 and is headquartered in Waltham, MA. | Health Technology |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Tufts Medical Center, Inc. owns and operates an academic medical center. It provides healthcare services and programs in the areas of allergy, anesthesiology, bariatric surgery, cancer, cardiology, colon and rectal, clinical nutrition, dentistry, dermatology, ENT/otolaryngology, endocrinology, diabetes and metabolism, gastroenterology, general surgery, geriatrics, hematology/oncology, hyperbaric medicine, infectious diseases, maternity, nephrology, neurology, neurosurgery, and nutrition. The firm also offers services in the areas of obstetrics and gynecology, occupational therapy, ophthalmology, orthopedics, otolaryngology, pain management, palliative care, pathology, pediatrics, physical medicine, physical therapy, plastic surgery, psychiatry, pulmonary, radiation oncology, radiology, rheumatology, speech language pathology and audiology, thoracic and transplant surgery, trauma surgery, urology, vascular surgery, wound healing, and weight and wellness. The company was founded in 1796 and is headquartered in Boston, MA. | Health Services |
New England Eye Center
New England Eye Center Medical/Nursing ServicesHealth Services New England Eye Center offers a full range of ophthalmology services. It specializes in cornea, external disease, and cataracts; glaucoma; oculoplastics; pediatric ophthalmology; retinal and macular diseases; vision rehabilitation; uveitis and immunology; pediatric optometry; and vision correction surgery. The company is headquartered in Boston, MA. | Health Services |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
Thaena, Inc.
Thaena, Inc. BiotechnologyHealth Technology Thaena, Inc. engages in biotechnology industry. The company was founded in 2019 and is headquartered in Portland, OR. | Health Technology |
